Financial reports
10-Q
2016 Q1
Quarterly report
10 May 16
10-K
2015 FY
Annual report
23 Feb 16
10-Q
2015 Q3
Quarterly report
4 Nov 15
10-Q
2015 Q2
Quarterly report
5 Aug 15
10-Q
2015 Q1
Quarterly report
6 May 15
10-K
2014 FY
Annual report
20 Feb 15
10-Q
2014 Q3
Quarterly report
6 Nov 14
10-Q
2014 Q2
Quarterly report
7 Aug 14
10-Q
2014 Q1
Quarterly report
7 May 14
10-K
2013 FY
Annual report
4 Mar 14
Current reports
8-K
Completion of Acquisition or Disposition of Assets
18 Jul 16
8-K
Entry into a Material Definitive Agreement
7 Jun 16
8-K
Zimmer Biomet to Acquire LDR to
7 Jun 16
8-K
Entry into a Material Definitive Agreement
13 May 16
8-K
LDR Holding Corporation Reports First Quarter 2016 Results
10 May 16
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 16
8-K
Regulation FD Disclosure
31 Mar 16
8-K
Regulation FD Disclosure
23 Feb 16
8-K
LDR Holding Corporation Reports Record Revenue for Fourth Quarter and Fiscal Year 2015
17 Feb 16
8-K
Entry into a Material Definitive Agreement
20 Jan 16
Registration and prospectus
15-12B
Securities registration termination
25 Jul 16
SC 14D9/A
Tender offer solicitation (amended)
13 Jul 16
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jul 16
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jul 16
25-NSE
Exchange delisting
13 Jul 16
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jul 16
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jul 16
POS AM
Prospectus update (post-effective amendment)
13 Jul 16
SC TO-T/A
Third party tender offer statement (amended)
13 Jul 16
SC 14D9/A
Tender offer solicitation (amended)
27 Jun 16
Other
EFFECT
Notice of effectiveness
25 Jul 16
CT ORDER
Confidential treatment order
5 Jul 16
UPLOAD
Letter from SEC
13 May 16
CORRESP
Correspondence with SEC
6 May 16
CORRESP
Correspondence with SEC
6 May 16
CT ORDER
Confidential treatment order
5 May 16
UPLOAD
Letter from SEC
29 Apr 16
UPLOAD
Letter from SEC
4 Aug 15
CT ORDER
Confidential treatment order
29 Jul 15
CORRESP
Correspondence with SEC
28 Jul 15